Advanced Adenoma
12
4
4
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (12)
China Colorectal Cancer Screening Trial 1 (C-Cost1)
A Novel Oral Synbiotic Formula in Reducing Advanced Adenoma Recurrence and Colorectal Neoplasia-related Bacterial Gene Markers
China Colorectal Cancer Screening Trial 2 (C-Cost2)
Diagnostic Accuracy of M3 in Predicting Colorectal Advanced Adenoma Recurrence (M3-AA)
Exploratory Study of a Novel Based rbcDNA Liquid Biopsy Technique for Colorectal Cancer Early Detection
Liquid Biopsy Based Multiomics Study for Colorectal Cancer Early Screening
Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC)
Prospective, Randomized Controlled Study to Evaluate the Effect of Artificial Intelligence Assisted Optical Diagnosis of Advanced Adenomas
A Stool DNA Test for Detection of Advanced Colorectal Neoplasia in Asymptomatic Chinese Community Population
Multitarget Stool FIT-DNA Study for Colorectal Cancer Early Screening in China
Colorectal Cancer Screening Using Stool DNA-based SDC2 and SFRP2 Methylation Test in China
Diagnosis of Colorectal Cancer and Advanced Adenoma Using Cancer-specific Methylation Signatures